Chronic Pain
Conditions
Keywords
Chronic Pain, Yogatherapeutics
Brief summary
In a context where yoga is more and more popularized in France and in Europe, and where Yogatherapy (as complementary medicine) begins to make its place in the care of patients in French hospitals, it seems interesting to study the impact of yoga in the chronic pain patient treated in a specific pain consultation by this non-pharmacological approach, and accessible.
Detailed description
Yoga is a discipline that has its origins in India for nearly 5,000 years, and which aims to bring physical, mental and spiritual well-being through postures, stretching, breathing exercises and meditation. Non-invasive and having very few side effects, this approach allows the practitioner to reclaim their body, to know themselves better, to accept their limits, to respect them and to empower themselves in their care and pathology. More and more studies are now looking at the positive effect of yoga whether it is on stress by demonstrating the drop in cortisol in participants, or on the reduction of symptoms of depression, improvement of immune function, or pain. To our knowledge, no study of the impact of yoga for analgesic treatment has been carried out in France. Through this retrospective study, the investigators wish to demonstrate a reduction in pain and / or an improvement in the quality of life.
Interventions
OTHERYogatherapy
Description: Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy
Sponsors
Hôpital NOVO
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient ≥ 18 years old, * Seen in consultation for chronic pain with implementation of Yogatherapy,
Exclusion criteria
* Patient \< 18 years old, * No indication for Yogatherapy treatment (Severe cognitive disorder / Major unbalanced psychological disorder), * Trauma pathology and / or acute fracture in progress, * Patient refusal to participate.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evolution of the patient's pain | Between the 1st and the 5th consultation, an average of 3 to 5 month | The evolution of the patient's pain is assessed by comparing the pain between the 1st and the 5th consultation, using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Evolution of the patient's pain over time | Between the 1st and the 5th consultation, an average of 3 to 5 month | The evolution of the patient's pain is assessed by comparing the pain between the 1st and the last consultation (number 10 maximum), using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable) |
| Improvement of patient's sleep | Between the 1st and the last consultation, an average of 5 to 10 month | The impact of pain on sleep is evaluated by questioning the patient at the first and last consultation (number 10 maximum) The answer to the question is YES or NO |
| Evolution of the patient's quality of life | Between the 1st and the last consultation, an average of 5 to 10 month | The quality of life is assessed at all visits, by questioning patient, on the following elements: work, daily activities, mood…. to obtain a score on a numerical scale between 0 and 10 Results are interpreted as following : EN ≤ 5 = Very degraded, 6 ≥ EN ≤ 7 = Degraded and EN \> 7 = Normal) |
| Evolution of the patient's therapeutic | Between the 1st and the last consultation, an average of 5 to 10 month | The evolution of the therapeutic is evaluated by questioning the patient at the first and last consultation (number 10 maximum) about their treatment: treatment name, indication, dosage, number of doses per day, decrease or increase for each treatment ……. to see if there is a decrease or not in the patient's therapies. |
Countries
France
Outcome results
None listed